Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2019 | 2 |
2020 | 1 |
2021 | 1 |
2022 | 2 |
2023 | 1 |
2024 | 0 |
Search Results
6 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Eprenetapopt Plus Azacitidine in TP53-Mutated Myelodysplastic Syndromes and Acute Myeloid Leukemia: A Phase II Study by the Groupe Francophone des Myélodysplasies (GFM).
J Clin Oncol. 2021 May 10;39(14):1575-1583. doi: 10.1200/JCO.20.02342. Epub 2021 Feb 18.
J Clin Oncol. 2021.
PMID: 33600210
Free PMC article.
Clinical Trial.
Subcutaneous azacitidine maintenance in transplantineligible patients with acute myeloid leukemia: a single-center retrospective study.
Johnson N, Templé M, Friedrich C, Willems L, Birsen R, Vignon M, Deschamps P, Franchi P, Mondesir J, Deau-Fischer B, Miekoutima E, Boussaid I, Chapuis N, Kosmider O, Bouscary D, Tamburini J, Decroocq J.
Johnson N, et al. Among authors: miekoutima e.
Haematologica. 2023 Oct 1;108(10):2850-2854. doi: 10.3324/haematol.2022.282009.
Haematologica. 2023.
PMID: 36994502
Free PMC article.
No abstract available.
Item in Clipboard
Synergistic effects of PRIMA-1Met (APR-246) and 5-azacitidine in TP53-mutated myelodysplastic syndromes and acute myeloid leukemia.
Maslah N, Salomao N, Drevon L, Verger E, Partouche N, Ly P, Aubin P, Naoui N, Schlageter MH, Bally C, Miekoutima E, Rahmé R, Lehmann-Che J, Ades L, Fenaux P, Cassinat B, Giraudier S.
Maslah N, et al. Among authors: miekoutima e.
Haematologica. 2020 Jun;105(6):1539-1551. doi: 10.3324/haematol.2019.218453. Epub 2019 Sep 5.
Haematologica. 2020.
PMID: 31488557
Free PMC article.
Item in Clipboard
Patients with Hematological Malignancies Treated with T-Cell or B-Cell Immunotherapy Remain at High Risk of Severe Forms of COVID-19 in the Omicron Era.
Zerbit J, Detroit M, Meyer A, Decroocq J, Deau-Fischer B, Deschamps P, Birsen R, Mondesir J, Franchi P, Miekoutima E, Guerin C, Batista R, Bouscary D, Willems L, Vignon M.
Zerbit J, et al. Among authors: miekoutima e.
Viruses. 2022 Oct 27;14(11):2377. doi: 10.3390/v14112377.
Viruses. 2022.
PMID: 36366475
Free PMC article.
Item in Clipboard
The transfusion of non-prophylactically RH-KEL1 antigen-matched red blood cells is feasible in selected myelodysplastic syndrome and acute myeloid leukaemia patients.
Xhaard A, Miekoutima E, Pirenne F, François A, Tiberghien P, Sebert M, Adès L, Fenaux P, Leprêtre AC.
Xhaard A, et al. Among authors: miekoutima e.
Vox Sang. 2022 May;117(5):693-700. doi: 10.1111/vox.13237. Epub 2022 Jan 5.
Vox Sang. 2022.
PMID: 34985763
Item in Clipboard
Respective roles of migration and social deprivation for virological non-suppression in HIV-infected adults on antiretroviral therapy in France.
Raho-Moussa M, Guiguet M, Michaud C, Honoré P, Palacios C, Boué F, Azghay M, Kansau I, Chambrin V, Kandel T, Favier M, Miekoutima E, Sayre N, Pignon C, Shoai M, Bouchaud O, Abgrall S.
Raho-Moussa M, et al. Among authors: miekoutima e.
PLoS One. 2019 Mar 7;14(3):e0213019. doi: 10.1371/journal.pone.0213019. eCollection 2019.
PLoS One. 2019.
PMID: 30845270
Free PMC article.
Item in Clipboard
Cite
Cite